Ignite Creation Date:
2024-05-06 @ 7:24 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02525939
Status:
COMPLETED
Last Update Posted:
2022-10-12
First Post:
2015-08-13
Brief Title:
Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS
Sponsor:
DalCor Pharmaceuticals
Organization:
DalCor Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Coronary Syndrome |
Keywords: